Quick Dispatch:
Your iih glp-1 NeuroOp Guru: Stopping GLP-1 therapy may trigger recurrent papilledema in IIH cases | Ophthalmology Times orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your iih glp-1 NeuroOp Guru: Stopping GLP-1 therapy may trigger recurrent papilledema in IIH cases | Ophthalmology Times ships.
Need Help?
Questions about iih glp-1 NeuroOp Guru: Stopping GLP-1 therapy may trigger recurrent papilledema in IIH cases | Ophthalmology Times, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for iih glp-1 NeuroOp Guru: Stopping GLP-1 therapy may trigger recurrent papilledema in IIH cases | Ophthalmology Times in your area.
GLP-1 Agonists May Help Reduce Use of Acetazolamide in IIH
20.35
Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals
28.61
IIH (Idiopathic Intracranial Hypertension): Symptoms, Diagnosis & Treatment
27.03
Abstract 447: GLP‐1 Receptor Agonists and Idiopathic Intracranial Hypertension: A Propensity Score‐Matched Study
28.12
A retrospective cohort study assessed outcomes among patients with idiopathic intracranial hypertension who received glucagon-like peptide-1 receptor agonists
25.67
GLP-1 Receptor Agonists Significantly Improve Effects of Idiopathic Intracranial Hypertension
26.80
Recurrent Idiopathic Intracranial Hypertension–Related Papilledema After Abrupt Discontinuation of Semaglutide: JNO Article: https://bit.ly/JNO_recurr_IIH_GLP1RA #brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology #Medicine #Papilledema
25.62
